Ladies and gentlemen, thank you for standing by. My name is Brent, and I will be your operator today. At this time, I would like to welcome everyone to the Hims & Hers Health Second Quarter 2022 Earnings Call. It is now my pleasure to turn today's call over to Mr. Jay Spitzer, Senior Vice President of Investor Relations. Please go ahead.

Good afternoon, ladies and gentlemen. Welcome to the Hims & Hers Health Second Quarter 2022 Earnings Call. On the call with me today is Andrew Dudum, Co-Founder and our Chief Executive Officer; as well as Yemi Okupe, our Chief Financial Officer. Before I hand you over to Andrew, I will, as usual, take you through the legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on our current market, competitive and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions or otherwise. Please see our most recently filed 10-K and 10-Q for a discussion of risk factors as they relate to forward-looking statements. In today's presentation, we have certain non-GAAP financial measures. We refer you to the reconciliation table contained in today's press release available on our Investor Relations website for reconciliations to the most directly comparable GAAP financial measures and related information. You'll find a link to the webcast and Investor Relations website at investors.forhims.com. After the call, this webcast will be archived on the website for 12 months. And with that, I'll now turn the call over to Andrew.

Thanks so much, Jay. Good afternoon, everyone, and thank you all for joining us today. It's an exciting time for Hims & Hers and I'm thrilled to share our Q2 results with you. Q2 was outstanding across the board as we execute on our mission to empower everyone to feel great through the power of better health. Our performance this quarter, on the heels of our breakout Q1, reflects the power and strength of our model, which is driving robust consumer demand across the business at a pace we believe is unparalleled in the consumer health and wellness space. Revenue, which is predominantly driven by recurring online subscriptions, grew 87% year-over-year to $114 million in the second quarter. With year-to-date revenue up 90% to $215 million. For the second straight quarter, we saw record quarterly growth in the number of net new subscriptions, up 107,000 in the quarter and ending the period at 817,000 as our brand continues to build momentum. Importantly, our planned investments in the quarter drove increased demand and allowed us to capture operational efficiency gains as we leverage our vertical fulfillment capabilities. The combination of robust consumer demand, strong gross margins, and continued operational leverage enabled us to maintain a modest adjusted EBITDA loss of $7.5 million in the quarter. Underpinning this strong performance and momentum is our consumer-centric business model and unique flywheel strategy. Our flywheel ignites by creating deep, meaningful, and lasting relationships with a variety of customers. We do this in a powerful way by creating an unparalleled brand and experience via an ecosystem that includes omnichannel retailers, celebrities, innovative products, technology, and suppliers and, of course, providers. Each element of this ecosystem can drive success on its own, but we see the most compelling results when they work harmoniously together to deliver a unique and beloved experience. With each passing quarter, my conviction in our strategy grows. I believe this opportunity to redefine consumer health and wellness to be a once-in-a-generation opportunity. I couldn't be more energized by our team's consistent execution and in turn, how our business is scaling. As we've discussed in the past, the intersection between a trusted brand, innovative technologies and products, and ultimately a world-class consumer experience is how we believe we win long term. This quarter, we executed with strength across these three long-term pillars, helping lay the foundation for continued value creation and long-term relationships with our customers. Let me begin with our trusted brand. During Q2, we leaned in heavily on planned investments to build greater brand awareness and equity. At a time when many companies were pulling back spending due to a softening demand environment, we took advantage of the marketplace opportunities from a position of strength to reinvest some of our top-line growth into our greatest asset, the Hims & Hers brand. We ran multiple diversified marketing campaigns within the quarter, most notably during the NBA finals, and the investments are delivering immediate results and tailwinds. Across all of our traffic metrics, more consumers than ever before are coming to the Hims & Hers platform. We connect with consumers like nobody else with authenticity that normalizes the challenges we all struggle with. These conversations create trusted relationships with a variety of consumers at a formative time in their lives, which we believe paves the way for us to become a long-term partner throughout their health and wellness journeys. We also continued to build brand awareness through our omnichannel distribution strategy. In Q2, we gained traction with two marquee retail partners, CVS and Walgreens. We launched six new women's essential supplements and probiotics, both on our own platform and exclusively in CVS locations nationwide. These new offerings are focused on daily support of general health, mental wellness, gut health, digestive health, skin, and libido. In addition, we expanded our presence in Walgreens with the rollout of both Hims & Hers hair care lines in over 7,000 stores throughout the country. Our strategic presence in the wholesale channel is extending our reach, building increased awareness, and introducing our brands to a broader audience of consumers. Moving now to technology and innovation. Helping people feel great means delivering a health and wellness experience that's different, one where the tools, products, and services are incredible and personalized to each of us. This is where our team excels, constantly innovating and raising the bar to create a superior customer experience. At the core of our marketplace is a unique technology platform that connects consumers with providers eager to help them solve their health and wellness challenges. This platform powers the marketplace, helping deliver speedy and trusted results to customers, but also safe, clinically accurate, and rewarding experiences for our providers. Our technology platform is constantly evolving, helping match consumers and providers via marketplace liquidity and ultimately a differentiated experience for customers. In Q2, there was increased focus on routing efficiencies as well as expanding the capability set to enable more comprehensive clinical options for a growing set of categories, such as mental health and dermatology. The benefits of these efforts are widespread, from consumer delight relating to quality of interactions and speed of access to provider recruiting and retention as a result of provider ease of use and respect for the quality of the platform. In the second quarter, our marketplace powered north of 350,000 medical visits on average per month. As our business continues to grow, we believe the technology fueling these interactions will increasingly deliver differentiated capabilities and ultimately differentiated experiences. In addition to our marketplace technologies, we invested meaningfully this quarter in consumer-centric digital experiences. High engagement experiences, original content, and tools are a critical part of creating sticky customer relationships and ultimately drawing users back to our platform. We do this in a variety of ways, and one of the most impactful initiatives has been the introduction of our mobile applications, which have rapidly gained traction. In Q2, we designed and launched two separate apps. One for Hims and one for Hers on iOS, which has enabled us to engage with each audience with increased degrees of authenticity and personalization. As a new destination hub for our consumers, these applications house an expansive catalog of branded content, personalization tools, shopping experiences, and provider engagement. The benefits of these investments have been incredible. Through the app, consumers are engaging with our brand three times more than historically through our website, creating the potential for immense value that can expand past the initial purchase. We're excited to also reach our Android users with similar mobile apps that we expect to launch in the coming weeks. In the same way, our technology staff drives differentiated consumer experiences, so do our infrastructure capabilities in driving innovative physical products. Providing innovative products customized to our customers' needs is a critical component of our long-term strategy. While the majority of products sold on our platform today are generic formulations in nature, we believe the future is one where proprietary formulations and truly personalized products not available anywhere else will make up the majority of our business. In Q2, we continued to lay this foundation through near full integration of the Apostrophe compounding facility into our operations as part of last year's acquisition. Our continued investments in R&D and a trusted partner ecosystem make us well-equipped to provide truly differentiated offerings. We believe our ability to deliver on these innovations will unlock further customer demand, brand loyalty, and ultimately, more valuable relationships. I've seen in recent product expansion offerings across dermatology and hair care businesses, these innovative and personalized products are representative of the next wave of consumer-centric care and are resulting in meaningful improvements to adoption and retention. We made great progress this quarter on these R&D initiatives, including through continued focus on the development of our 25,000 square foot compounding facility. We believe these infrastructure capabilities will give us the scale, quality, and efficiencies needed to mass-produce these proprietary offerings at an affordable price. The strategies and initiatives I've just discussed are built upon our ever-improving infrastructure capabilities to accept an order, verify treatment safety, and deliver to any door in the nation within days. We continue to make investments in operational excellence at our Ohio and Arizona facilities. I'm happy to report that the majority of our shipments are now filled and shipped via these centers. Our constantly improving capabilities to provide access to such a variety of medical products and formulations, form factors, and bundles is a key driver of our success. Speed, efficiency, and flexibility of scale allows us to own the consumer experience from start to finish. In addition, as seen from improved operational leverage, our continued expansion of internal infrastructure allows for long-term margin efficiencies and competitive pricing advantages. In Q2, we continued to unlock and redeploy these operational gains against the flywheel, further bolstering our brand, technology, and capabilities, which I believe will continue to set us apart and pay long-term dividends. As we look ahead, we feel ideally positioned to build on the momentum we're seeing across the business. This has allowed us the unique fortune to invest for future growth while organically driving our path to profitability. As we announced in today's press release, we are raising our full-year outlook for 2022 revenue and adjusted EBITDA. Importantly, our ability to capture operational efficiency improvements while scaling the business is expected to result in adjusted EBITDA profitability within the next four quarters. Before turning the call to Gene to discuss the financials, I want to thank our teams across the organization for their strong execution and dedication to our mission to empower everyone to feel great through the power of better health. I'm incredibly proud of what we have built in just five years' time and look forward to keeping you all updated on our continued progress. Now over to Yemi.

Thank you, Andrew. Good afternoon, everyone, and thanks for joining us. I will now provide additional insight into our second quarter performance as well as our outlook for the remainder of the year. I will also provide additional visibility into our expectations around profitability timing. Great execution among our teams allowed us to deliver a solid performance across the board. In the second quarter, we continued to see strong momentum within each pillar of our business: our brand, technology, and seamless experience through operational excellence. Success across these dimensions continues to drive robust performance. Revenue grew 87% year-over-year in the second quarter to $113.6 million. We mentioned in the last earnings call that we saw an opportunity to lean into marketing spend to expand our core categories, build awareness of our newer offerings, and start to experiment with additional channels. The outcome from that decision surpassed our expectations. Online revenue increased 85% year-over-year to $107.5 million. Similar to the first quarter, growth in the online channel came primarily from subscriptions. The number of subscriptions on our platform grew 107,000 from the prior quarter to 817,000, representing an increase of 80% from the second quarter of last year. Subscriptions increased as a result of increased traffic combined with minimal degradation in conversion from the successful rollout of digital and brand campaigns. High appetite for a multi-month subscription future continues. Quarterly online revenue per subscription was flat quarter-over-quarter at approximately $132. This indicates an ability to expand our user base and maintain a similar engagement and revenue generation profile. Revenue through our wholesale channel increased 140% from the second quarter of last year to $6.1 million. We saw a revenue decline of $1.1 million relative to the first quarter as a result of lapping initial inventory purchases from larger partners such as Walmart. While we expect revenue growth in this channel to moderate for the next couple of quarters, our wholesale channel remains a critical part of our flywheel, driving higher consumer awareness and trust across our online channels. Gross margin increased 300 basis points relative to the first quarter to 77%. The majority of this gain came from improved efficiency within our operations, combined with benefit from a greater share of revenue from our online channel. To date, we have not experienced material supply chain challenges within our operations. In large part due to the recent growth of our business, we have seen many suppliers eager to partner with us to ensure that this dynamic remains. As a further safeguard, we increased the inventory of our most popular products that carry multiyear shelf lives as we head into the second half of the year. SG&A costs as a percentage of revenue declined 170 basis points relative to the first quarter to 41% of revenue. When excluding stock-based compensation, SG&A expenses declined 230 basis points to 33%. These gains are largely a reflection of continued operating leverage from the business. Marketing as a percentage of revenue increased 580 basis points quarter-over-quarter to 53% in the second quarter. When excluding stock-based compensation, marketing expenses and share of revenue increased 570 basis points to 52%. This increase is in line with the remarks highlighted in last quarter's earnings call. A meaningful portion of the higher investment went towards brand campaigns, which we expect we will continue to benefit from in future quarters. Adjusted EBITDA for the quarter was negative $7.5 million. Despite a significant increase quarter-over-quarter in marketing investment, adjusted EBITDA margins declined modestly to negative 7%. This is a result of stronger gross margins, continued leverage on SG&A expenses, combined with the high bar from the marketing investments that we hold. We are pleased with the performance of the business in the first half of the year. Several favorable dynamics have fueled solid performance across both revenue and adjusted EBITDA. These include an ability to maintain strong payback periods of less than a year on our marketing investments, successful introduction of additional marketing campaigns, which has driven growth across several categories in the form of greater audience reach and consumer trust, the rollout and continued adoption of innovative products that consumers are engaging and adopting inclusive of our mobile app, new form factor solutions and new product offerings, and lastly, a rigorous focus on continuing to capture more efficiencies across our business operations. Before getting into the details of our guidance, I'd like to reiterate the key assumptions that we outlined last quarter, all of which remain unchanged but nonetheless, I think, are helpful to add further perspective around how we view the remainder of the year. The first is long-term retention. We've meaningfully increased our customer base over the last two quarters and have seen signals that long-term online revenue retention will remain at least 85%. Embedded in our outlook is that this dynamic continues. Marketing investment in the second quarter was more aggressive than prior quarters. We saw success with our NBA Finals ad campaign as well as an overall more favorable environment for marketing spend as many companies scaled back. We are anticipating that the environment remains favorable through the third quarter. You can expect marketing as a percentage of revenue in the third quarter to be comparable to the second quarter if that holds true. Given our outlook for the rest of the year, and the strong fundamentals and patterns we are seeing across the business, we are increasing our outlook for both revenue and adjusted EBITDA for the remainder of the year. For the third quarter, we anticipate revenue of between $129 million and $132 million which would represent 74% to 78% year-over-year growth in the third quarter of 2021. Our expectation is that adjusted EBITDA losses will be between $7 million to $9 million, which would represent an adjusted EBITDA margin of negative 6% at the midpoint of our adjusted EBITDA and revenue ranges. For the full year, we are raising our revenue outlook to between $470 million and $485 million, which represents year-over-year growth of between 73% and 78%. We expect adjusted EBITDA losses of between $27 million to $20 million for the year, representing an adjusted EBITDA margin of negative 5% at the midpoint of our adjusted EBITDA and revenue ranges. I'll now take a moment to provide additional color on our expectations for generating positive adjusted EBITDA. We shared with you last quarter that we had direct line of sight to positive adjusted EBITDA. Given the strong underlying momentum of the business, we expect to achieve positive adjusted EBITDA within the next four quarters. Our aim is to continue to focus our investments towards activities that fit within the parameters of our capital allocation framework. As a reminder, these are line of sight to a payback period of less than a year, investments that have an ability to drive long-term growth while capturing economic benefits from greater scale, and significant potential for high return on investment. Exact timing for attainment of this critical milestone is dependent on several factors, including our investment decisions and performance across our emerging categories and channels. Several areas that we have invested in have exceeded our performance expectations by a wide margin. If this trend continues, we could achieve profitability as early as the fourth quarter of this year as implied by the top end of our adjusted EBITDA outlook. We have seen several elements of our flywheel continue to compound in a meaningful way. Our brand continues to resonate with customers, which has resulted in continued growth in subscriptions on our platform. As a result of new customer growth, key partners are actively engaging with us, whether that be for creative marketing campaigns, new distribution channels, or supply chain relationships. Technology advances continue to delight our users and drive higher engagement across our platform, whether it be through how they engage with our platform or innovative and highly effective form factors. These positive dynamics have enabled us to realize benefits from economies of scale and drive leverage across several areas of our operations. It is clear that our business is evolving. As a result of this evolution, we feel that it is important to provide additional transparency into the underlying cost structure of our business. Starting next quarter, we plan to provide additional disclosures related to our operating expenses. This will provide greater clarity around investment areas and our continued progress at driving efficiencies across our operations. We look forward to sharing that detail with you next quarter in our third quarter SEC filings. I'd like to thank our customers, partners, and employees who continue to help us achieve such strong results. With that, I will now turn it over to the operator for the Q&A portion of the call.

Your first question comes from Dan Grosslight with Citigroup.

Hi, guys. Thanks for taking the questions and congrats on another strong quarter here. If I just look at the cadence of your guidance for the remainder of the year, the midpoint gets you to around a 15% sequential increase in revenue in Q3. And then for Q4 it steps down to around 1% sequential growth. And then similarly, it looks like you expect adjusted EBITDA to drop from around $8 million in Q3 to $2 million in Q4. And Yemi, as you mentioned, you could even be positive in Q4. So I'm just curious if you're signaling to us that you're looking to titrate growth down a little in Q4 as you focus more on profitability? And if so, how should we think about that profitability versus growth dynamic heading into 2023?

Yes, Dan, thanks for the question. With respect to the third quarter guidance. What you do see is that many of the investments that we made in the second quarter came at the tail end of the second quarter. And so we do receive a tailwind heading into the third quarter. With respect to the profitability versus growth dynamic in the fourth quarter, we continue to look for attractive opportunities to continue to invest and deploy dollars. So it's not as if we're going to scale back our marketing investment deliberately in any type of meaningful way, assuming that we still have the ability to investment initiatives that meet our capital allocation framework, we will continue to do so. But what we expect to see headed into the fourth quarter really is that the revenue that we pulled from the second quarter and the third quarter cohorts will start ticking down. And then I think the other dynamic here is that historically, the fourth quarter has been pretty volatile from a marketing investment perspective. We have seen some signals that the environment has remained favorable through the third quarter. Our guidance does not inherently assume that the fourth quarter, that dynamic will entirely remain. And so that is why we've left a pretty wide range in the full-year guidance.

Yes, yes, that makes sense. And I guess dovetailing off that a little bit and the volatility in the fourth quarter, I think, recession and the impact of the consumer seems to be on everyone's mind this quarter. So just curious how you factor that into your guidance, a potential recession, and then do you think that you could see some offsetting strength during the recession because more consumers are actually off of their employee insurance and need to go outside of the typical visit and could migrate to you guys?

Yes. Thanks for the question. I think, generally speaking, we feel really well positioned not only to thrive in a recessionary dynamic but also to really take meaningful share. I think this quarter is a great example, right? We leaned in aggressively to efficient marketing where it was working as others were pulling back. And then also remember, the categories that we're operating in are very emotionally challenged top-of-mind customer needs that when these customers are waking up, they are the things we're thinking about. And so I really feel like we've got a diversified set of customers that are coming to us with deep emotional relationships for things they care about. And ultimately, that's just a really sticky relationship that I think is really different from most in the market.

Your next question comes from the line of Michael Cherny with Bank of America.

Hi, this is Charlotte on for Mike. Thanks for taking my question and congrats on the great quarter and your comments on profitability. Could you just provide some more color around your expectations for wholesale in the back half of the year, just going off of what you mentioned earlier?

Yes, Charlotte, thanks for the question. I mean I think we don't provide explicit guidance for the wholesale channel. What we do expect is for moderate growth to continue through the back half of the year. Again, what I would reiterate around our wholesale channels, we do view that as a critical channel that's part of our flywheel to generate eyeballs for our online channel. But we do expect more of a moderate pace of growth in the back half of the year.

Got it. And then just a second question. On your facilities in Ohio and Arizona. Just if you could provide any more details on the efficiencies you're seeing coming out of that part of the business.

Yes. So at a high level, the things we're really excited about there are the flexibility and customization that can come from not verticalization, right? As we broaden the bundle that we offer on the platform, innovative products, the combination of those products, being able to allow customers to, in real time, adjust in real-time add or subtract, change frequencies of deliveries and cadences, we feel like really unlocks the level of personalization that benefits the long-term relationship with the customer. And this is something that's just really difficult to do when you're talking about a third-party pharmacy or fulfillment center. So I think that's something that we feel is really critical differentiation. At this point, as we mentioned, the majority of our monthly treatment orders are being delivered through these facilities. So we expect to continue to make that transition to near 100%. And as we're also seeing on the margin front, there's incremental benefits from an efficiency and leverage standpoint as we bring those more in-house.

Your next question is from the line of Jessica Tassan with Piper Sandler.

Hi, thanks so much for taking my question and congrats on the quarter. I was hoping you could just remind us how you define long-term customer retention. And then just if that 85% long-term customer retention rate persists, how should that impact what I think you mentioned was an average order value per subscription of around $135? And then what does that mean for AOV over the next couple of years?

Yes. Thanks for the question. Jessica, to answer your question around how we define long-term retention. Effectively, what that is, it's the revenue coming from customers that have been on the platform for at least two years. And then basically, what occurs is we retain 85% of the revenue from those customers on a go-forward basis. With respect to how that can evolve and influence the revenue per subscription was a metric that we gave. We don't provide closer guidance around that. What we do expect is to hold to some of the similar trends that we've seen with respect to AOV in prior quarters, where we'll see moderate to slightly up year-over-year AOVs from the prior year.

That's helpful. And then just maybe any commentary you could give on just AOV trends in the back half of the year. And I think just any color on what is driving kind of this really consistent AOV at least on a sequential basis. And that's it for me. Thanks.

Sure. I think with respect to AOV, I think it largely holds true of the commentary that we gave earlier. We do expect AOV to be slightly up year-over-year. With respect to what's driving the AOV dynamics, largely what that is, it's a function of product mix. Consumers are coming to the platform and ordering a mix of baskets that tends to carry higher order values, both in the terms of the duration of subscriptions that they're choosing as well as in terms of the types of products that they're choosing.

Your next question is from the line of George Hill with Deutsche Bank.

Hi, it's Maxi on for George. Thanks for taking the question. I want to start with marketing spend. You mentioned the environment continues to be favorable. Can you provide some more color on what you're seeing on spending the rate or costs going up or down? How do you plan to explore the changes in the market?

Yes, sure. So I think maybe I'll start. What we have seen across the board is generally for the majority of our categories, we did see customer acquisition costs come down. What we did have to do this quarter was tilt some of the investment towards some of the more emerging categories. Additionally, as I mentioned, a lot of the investment that we had was back-end weighted, really, as we started to see the environment start to shift later in the second quarter. Our expectation is that, that will continue in Q3. The final element that we did do is, I think, as Andrew has mentioned previously, we oftentimes explore with a variety of channels. One of the channels that we didn't lean in more aggressively with this quarter, which is our overall brand spend. You do see our activities like us placing ads in the NBA finals. Our belief is that while we saw some pretty sizable returns on that immediately, many of those gains will start to accrue over the long run.

I think just to add color there. We're really looking for opportunities to lean in here because during these recessionary times and to Dan's earlier point, we are seeing the competitive landscape tightening their belts and starting to attract from a lot of these channels, which creates an opportunity for us to really capture a disproportionate size of the market in the next coming quarters. So while we have the advantages in front of us and as the operational leverage increases internally, we feel like it's really an incredible move to lean in where we can and to capture the growth of that subscription base while it's on the table.

Okay. That's very helpful. I have a quick follow-up. Are you seeing any rises in demand for birth control and related drugs due to the regulatory change? And do you expect to see any benefit on the results from that? Thanks.

We have seen some increased demand on the Hers side of the business, specifically for the near dozen contraception options that we have on the platform. We haven't seen a huge amount of inbound relating to other related services, which I know is a very hot topic in the news right now. It is something we're looking at and we're evaluating the legal landscape to see if there is an opportunity for us to help women in different circumstances. But at this point, most of that balance and increase in demand has really come from the contraception side of the business.

Your next question comes from the line of Jack Wallace with Guggenheim Securities.

Thank you for addressing my question. Andrew, we should have taken note when you referred to breakout performance multiple times in the last call. This has certainly been another impressive performance from your team. I would like to revisit some topics we've discussed. From what I'm understanding, it appears the advertising environment is becoming more favorable for you in terms of costs. You're increasing your spending in that area and seeing positive returns, which is aimed at driving near-term growth. However, it seems you're also reinvesting those profits into larger, long-term brand-building efforts. Is that an accurate way to view how the funds are being reinvested overall? Additionally, I see there is some focused spending on emerging categories.

Yes, I believe that's a reasonable perspective. In our approach to capital allocation, we utilize a mix of different strategies. One aspect focuses on increased experimentation. We were very pleased with the brand outcomes during the second quarter, and we plan to continue experimenting and expanding our brand into new channels in the third quarter. As mentioned earlier, we view our investments not just as a means to secure individual transactions in a given quarter, but more about establishing long-term relationships with our customers. This strategy will yield benefits not only in the current quarter but over several quarters ahead. This is one reason we are confident in our path to profitability within the next four quarters. Even with our investments, the consistent nature of our footprint and the durability of our customer base bolster that confidence.

Yes, I think to add on to that, Jack, the ability to leverage the benefits of the established categories and reinvest that as well on the emerging categories, particularly, I think it's a really valuable part of this business that has created a degree of defensibility and diversity of audience and channel and category that really is hard to find in other businesses. We are literally marketing to dozens of different types of customers, dozens of different types of offerings on dozens of different types of channels, right? And so that matrix allows us to flex up and down in different ways and to carry over profitability in one very core and flywheel category to the next category that's accelerating. And so I think not only is the recurring nature of that and the diversity, to Yemi's point, giving us confidence in the profitability timeline, but I think that's also giving us increased confidence and is a big part of the raise in guidance this quarter and the ability for us to have a really great long-term high-growth trajectory, right? There are multiple engines underneath the brands, Hims and Hers, each of which are great businesses. And so our ability to continue to unlock those at scale, we think, is a real asset to the company.

That's really helpful. And then just are there any KPIs or maybe some kind of overarching commentary you can give us about how your customers will interact and potentially purchase more products if they have downloaded the mobile app versus if they're solely engaging through the website?

Yes, it's a great question, Jack. So the mobile app has really been one of the most impactful initiatives that we've released this past quarter and have a very, very strong belief that this platform and this kind of health care hub that we're creating will ultimately draw users back to the platform, drive stickier engagement, and higher customer value. We launched this quarter, two separate apps, one for Hims and one for Hers that has allowed us a degree of personalization and authenticity in that experience that's paid a lot of dividends. The metric that we've disclosed, which I think is a really important metric and one that we're starting to really track is the increase in engagement with the platform. So through the app, consumers are now engaging with our brands three times more than historically they were on our web properties, which we believe is creating the potential for immense value that takes place after that initial purchase. So as we continue to expand offerings on the platform as we continue to roll out in the mobile application, more catalog of original content, personalization tools, shopping experiences, and provider engagement options the ability to message them and talk to them at any point, 24/7. We think this is only going to increase. And ultimately, we think it's a really big part of the differentiated offering that customers are paying for with Hims and Hers service.

Your next question is from the line of Ivan Feinseth with Tigress Financial.

Thank you. Thank you for taking my question. Congratulations on another quarter and the ongoing success. From the accelerated marketing spend, where did you get the most impact? What lines of products did the best and what products and things surprised you with the response?

Yes, it's a great question. We had a lot of success in Q2, both in the core categories, which are the traditional men's categories such as dermatology, hair loss, sexual health, premature ejaculation, a lot of those original categories continue to scale very, very well. And so a lot of capital deployed there. Also seeing continued explosive growth on the emerging categories, specifically in the Hers side of the house. These categories, as we've shared last quarter, and I can share again this quarter, these are growing at triple-digit revenue growth. So they are the fastest parts of the business that are accelerating and growing. The economics of those businesses starting to look a lot like our best-in-class core categories and are generating pretty meaningful scale at this point. And so we drove a lot of dollars into those two engines and saw great returns. And then as Yemi said, I think we're also really surprised, frankly, at the outperformance of a lot of our brand spend. We deployed meaningful dollars into very high visibility spots such as the NBA finals that we know have long-term tailwinds associated, but we also saw very near-term benefits across all of our channels and raising the efficiencies of those channels. And so it was really this kind of convergence of the trifecta those areas, the core categories really doing their job to continue to build the engine, the emerging categories starting to accelerate in a way that it's starting to make up a larger percentage of revenue. And then this halo of the brand dynamic that I think, again, is creating tailwinds both immediately and long term.

And what are your marketing initiatives have you seen that drives the biggest repeat where customers sign on and continue to buy after their initial purchase?

We actually look on a channel basis by category basis and then actually target those categories with specific acquisition goals. Right? And so as Yemi said, we've got a very disciplined approach to pay marketing and to our marketing spend. We want a very clear payback period within 6 to 12 months and the ability to generate very positive returns on those investments. And so across all of our channels, they're optimized on a per-customer basis and a per-channel basis for their most optimal payback period. And so it's not one channel that's better than the other, depending on the customer and the condition, it really quite ranges.

Your next question comes from Joy Zhang with SVB Securities.

Hey guys, congratulations on a strong quarter and thanks for taking my questions. My first question is on the brand side. Can you just talk to what you see as advantages or disadvantages of being a multiproduct brand spanning many specialty areas versus your competitors who are solely focused on one area like hair loss or behavioral health? And relating to that, how do you maintain your brand value when some of the emerging competitors are using very similar aesthetics and advertising channels to market their products?

Thanks. It's a great question. From a brand perspective, we've always had the philosophy that long-term brand equity will really compound if you can put numerous, highly emotional, highly resonant categories under one umbrella, right? And that's why we named the company Hims and Hers from the beginning because it speaks to a customer and say, hey, we're here for a long time. We're going to build a deep and trusted relationship with you. And as you scale and as you age and it is more things pop up, we're going to do the same thing side-by-side, holding your hand. And so what we see with the Hims brand and the Hers brand is both the same, a huge advantage of being able to speak to one message around health, wellness, empowerment, feeling great that really resonates across the five or ten major categories that make up the majority of what people say is primary care. The reasons you're going into a doctor's office, the things that are making you feel better are things like sleep, your relationships with your partner, your mental wellness, your anxiety or depression, how you feel about yourself and your own skin, right, your weight, your skin, your hair. And so the focus on core emotionally relevant categories, but having that broad set umbrella on top has been a huge asset, right? It allows us to deploy one key message to customers in their brain to capture that airspace in their mind of Hims or Hers as their health and wellness partner and then over the course of the year, build with them and expand with them. And I think we've seen that in the data and we've seen that be a massive advantage. On the protection of the brand, what I would say is that there's really three components that drive the success of what's happening under the hood right now. It's the uniqueness and authenticity of the brand. It's the innovative technologies and the products we're actually offering. And then ultimately, it's the seamlessness, beauty, and functionality within the experience. So while other brands might take a peach color tone and put it on the background of an ad and feel like they're going to try to get the benefits of the Hims platform or the Hers platform, it's just frankly not the reality. In order to scale at these levels to deploy this amount of marketing efficiently, to retain close to one million subscriptions on a monthly basis with a deep relationship, you actually have to have the trifecta of all of those three. And so we spend a lot of time investing in the brands in an omnichannel way across 20,000 retail locations with different partnerships, celebrities, and suppliers. We invest a tremendous amount in the technology platform, original content, and mobile applications, the one-click ability to buy, talk to a doctor 24x7 all of this is what makes the experience world-class and ultimately deliver something that is truly better and unique than anything in market. And it's that flywheel that's delivering the outsized and kind of record-breaking returns, it's not the simplicity of maybe how an ad looks on a marketing channel.

That's super helpful. Thanks for that. And as a follow-up, you've always had a 100% cash pay model, and that's worked very well so far. Given the recessionary environment going forward, do you see any opportunities in engaging with managed care companies for certain higher-priced product lines? Or do you expect to remain under that cash pay model?

Yes, that's an excellent question. It's important to keep in mind that our business was created to address many of the inefficiencies that customers often encounter during times of recession. In health care, this includes limited access to services, especially in nonurban or suburban areas, which are frequently underserved by primary care physicians within a reasonable distance. Access is inconvenient, and prices tend to be high. Most customers using our platform have insurance, but many have high deductible plans. Interestingly, during recessionary periods, cash pay options can be quite advantageous for patients, allowing them to pay around $20 or $30 for a complete experience, including specialist access and product delivery. We are focused on providing affordable options and continually assessing how insurance might be beneficial. However, our cash pay prices are often more advantageous than standard co-pay prices, primarily due to the efficiencies we have built into our system. We are committed to exploring opportunities where insurance could support our customers, but in the areas we operate and are excited about, we believe we can offer cash pay prices that are more accessible and beneficial.

There are no further questions at this time. Ladies and gentlemen, thank you for your participation. This concludes today's call. You may now disconnect.